| A-T | Ataxia-Telangiectasia; |
| ATM | Ataxia-Telangiectasia mutated; |
| BMT | bone marrow transplantation; |
| DSBs | double strand breaks; |
| MRN | MRE11/RAD50/NBN; |
| V(D)J | variable (V), diversity (D) and joining (J); |
| AFP | alphafetoprotein; |
| SOD | superoxide dismutase; |
| ROS | reactive oxygen species; |
| IR | irradiation; |
| IGF-1 | insulin-like growth factor 1; |
| SMRT | small molecule read-through; |
| ASO | antisense oligonucleotides; |
| CRISPR/Cas9 | clustered regularly interspaced short palindromic repeats/CRISPR-associated protein-9; |
| iPS cells | induced pluripotent stem cells; |
| HSV-1 | Herpes simplex virus type 1 AAV: adeno-associated virus; |
| HSCs | hematopoietic stem cells; |
| BMDCs | bone marrow-derived cells; |
| GFP | green fluorescent protein; |
| Allo-HSCT | allogenic hematopoietic stem cell transplantation; |
| GvHD | graft-versus-host disease; |
| EBV | Epstein−Barr virus; |
| HLA | human leukocyte antigen; |
| RIC | reduced intensity conditioning. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.